Valion Bio (VBIO) Other Non-Current Assets (2021 - 2026)
Valion Bio (VBIO) posted quarterly Other Non-Current Assets of $124000.0 for Q4 2025, up 439.13% quarter-over-quarter from $23000.0 in Q3 2025.
Valion Bio (VBIO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Valion Bio's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $124000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Assets changed N/A year-over-year to $124000.0; the TTM figure through Dec 2025 stood at $124000.0 (changed N/A YoY), while the FY2025 annual figure was $124000.0, changed N/A from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $124000.0, up from $23000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $124000.0 in Q4 2025, with the low at $2000.0 in Q1 2025.
- The 5-year median for Other Non-Current Assets is $34000.0 (2022), against an average of $36071.4.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets grew 3.03% in 2023, then plunged 94.12% in 2025.
- Valion Bio's Other Non-Current Assets stood at $49000.0 in 2021, then tumbled by 30.61% to $34000.0 in 2022, then changed by 0.0% to $34000.0 in 2023, then changed by 0.0% to $34000.0 in 2024, then jumped by 264.71% to $124000.0 in 2025.
- Business Quant data shows VBIO's Other Non-Current Assets at $124000.0 in Q4 2025, $23000.0 in Q3 2025, and $2000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 62.96 Mn |
| 10 | Valion Bio | 404,923.65 | -1.80 Mn | -45,000.00 | 631,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 368,000.00 |
| Dec 31, 2025 | 124,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2024 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 34,000.00 |
| Jun 30, 2023 | 34,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 34,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 49,000.00 |